530 related articles for article (PubMed ID: 29625054)
1. A Pan-Cancer Analysis of Enhancer Expression in Nearly 9000 Patient Samples.
Chen H; Li C; Peng X; Zhou Z; Weinstein JN; ; Liang H
Cell; 2018 Apr; 173(2):386-399.e12. PubMed ID: 29625054
[TBL] [Abstract][Full Text] [Related]
2. Pan-cancer analysis of copy number changes in programmed death-ligand 1 (PD-L1, CD274) - associations with gene expression, mutational load, and survival.
Budczies J; Bockmayr M; Denkert C; Klauschen F; Gröschel S; Darb-Esfahani S; Pfarr N; Leichsenring J; Onozato ML; Lennerz JK; Dietel M; Fröhling S; Schirmacher P; Iafrate AJ; Weichert W; Stenzinger A
Genes Chromosomes Cancer; 2016 Aug; 55(8):626-39. PubMed ID: 27106868
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional dysregulation by aberrant enhancer activation and rewiring in cancer.
Okabe A; Kaneda A
Cancer Sci; 2021 Jun; 112(6):2081-2088. PubMed ID: 33728716
[TBL] [Abstract][Full Text] [Related]
4. A Tumor-Specific Super-Enhancer Drives Immune Evasion by Guiding Synchronous Expression of PD-L1 and PD-L2.
Xu Y; Wu Y; Zhang S; Ma P; Jin X; Wang Z; Yao M; Zhang E; Tao B; Qin Y; Chen H; Liu A; Chen M; Xiao M; Lu C; Mao R; Fan Y
Cell Rep; 2019 Dec; 29(11):3435-3447.e4. PubMed ID: 31825827
[TBL] [Abstract][Full Text] [Related]
5. The chromatin accessibility landscape of primary human cancers.
Corces MR; Granja JM; Shams S; Louie BH; Seoane JA; Zhou W; Silva TC; Groeneveld C; Wong CK; Cho SW; Satpathy AT; Mumbach MR; Hoadley KA; Robertson AG; Sheffield NC; Felau I; Castro MAA; Berman BP; Staudt LM; Zenklusen JC; Laird PW; Curtis C; ; Greenleaf WJ; Chang HY
Science; 2018 Oct; 362(6413):. PubMed ID: 30361341
[TBL] [Abstract][Full Text] [Related]
6. Identification of activated enhancers and linked transcription factors in breast, prostate, and kidney tumors by tracing enhancer networks using epigenetic traits.
Rhie SK; Guo Y; Tak YG; Yao L; Shen H; Coetzee GA; Laird PW; Farnham PJ
Epigenetics Chromatin; 2016; 9():50. PubMed ID: 27833659
[TBL] [Abstract][Full Text] [Related]
7. Gene landscape and correlation between B-cell infiltration and programmed death ligand 1 expression in lung adenocarcinoma patients from The Cancer Genome Atlas data set.
Ho KH; Chang CJ; Huang TW; Shih CM; Liu AJ; Chen PH; Cheng KT; Chen KC
PLoS One; 2018; 13(12):e0208459. PubMed ID: 30521597
[TBL] [Abstract][Full Text] [Related]
8. A High-Resolution Map of Human Enhancer RNA Loci Characterizes Super-enhancer Activities in Cancer.
Chen H; Liang H
Cancer Cell; 2020 Nov; 38(5):701-715.e5. PubMed ID: 33007258
[TBL] [Abstract][Full Text] [Related]
9. Leveraging Tissue-Specific Enhancer-Target Gene Regulatory Networks Identifies Enhancer Somatic Mutations That Functionally Impact Lung Cancer.
Hariprakash JM; Salviato E; La Mastra F; Sebestyén E; Tagliaferri I; Silva RS; Lucini F; Farina L; Cinquanta M; Rancati I; Riboni M; Minardi SP; Roz L; Gorini F; Lanzuolo C; Casola S; Ferrari F
Cancer Res; 2024 Jan; 84(1):133-153. PubMed ID: 37855660
[TBL] [Abstract][Full Text] [Related]
10. InTAD: chromosome conformation guided analysis of enhancer target genes.
Okonechnikov K; Erkek S; Korbel JO; Pfister SM; Chavez L
BMC Bioinformatics; 2019 Jan; 20(1):60. PubMed ID: 30704404
[TBL] [Abstract][Full Text] [Related]
11. Contribution of transposable elements and distal enhancers to evolution of human-specific features of interphase chromatin architecture in embryonic stem cells.
Glinsky GV
Chromosome Res; 2018 Mar; 26(1-2):61-84. PubMed ID: 29335803
[TBL] [Abstract][Full Text] [Related]
12. Enhancer Dysfunction in 3D Genome and Disease.
Xia JH; Wei GH
Cells; 2019 Oct; 8(10):. PubMed ID: 31635067
[TBL] [Abstract][Full Text] [Related]
13. Different enhancer classes in Drosophila bind distinct architectural proteins and mediate unique chromatin interactions and 3D architecture.
Cubeñas-Potts C; Rowley MJ; Lyu X; Li G; Lei EP; Corces VG
Nucleic Acids Res; 2017 Feb; 45(4):1714-1730. PubMed ID: 27899590
[TBL] [Abstract][Full Text] [Related]
14. CancerEnD: A database of cancer associated enhancers.
Kumar R; Lathwal A; Kumar V; Patiyal S; Raghav PK; Raghava GPS
Genomics; 2020 Sep; 112(5):3696-3702. PubMed ID: 32360910
[TBL] [Abstract][Full Text] [Related]
15. Systematic analysis of enhancer regulatory circuit perturbation driven by copy number variations in malignant glioma.
Xiao J; Jin X; Zhang C; Zou H; Chang Z; Han N; Li X; Zhang Y; Li Y
Theranostics; 2021; 11(7):3060-3073. PubMed ID: 33537074
[No Abstract] [Full Text] [Related]
16. CenhANCER: a comprehensive cancer enhancer database for primary tissues and cell lines.
Luo ZH; Shi MW; Zhang Y; Wang DY; Tong YB; Pan XL; Cheng S
Database (Oxford); 2023 May; 2023():. PubMed ID: 37207350
[TBL] [Abstract][Full Text] [Related]
17. MLL3 enhances the transcription of PD-L1 and regulates anti-tumor immunity.
Xiong W; Deng H; Huang C; Zen C; Jian C; Ye K; Zhong Z; Zhao X; Zhu L
Biochim Biophys Acta Mol Basis Dis; 2019 Feb; 1865(2):454-463. PubMed ID: 30385408
[TBL] [Abstract][Full Text] [Related]
18. Discovery of stimulation-responsive immune enhancers with CRISPR activation.
Simeonov DR; Gowen BG; Boontanrart M; Roth TL; Gagnon JD; Mumbach MR; Satpathy AT; Lee Y; Bray NL; Chan AY; Lituiev DS; Nguyen ML; Gate RE; Subramaniam M; Li Z; Woo JM; Mitros T; Ray GJ; Curie GL; Naddaf N; Chu JS; Ma H; Boyer E; Van Gool F; Huang H; Liu R; Tobin VR; Schumann K; Daly MJ; Farh KK; Ansel KM; Ye CJ; Greenleaf WJ; Anderson MS; Bluestone JA; Chang HY; Corn JE; Marson A
Nature; 2017 Sep; 549(7670):111-115. PubMed ID: 28854172
[TBL] [Abstract][Full Text] [Related]
19. Clinical applications of PD-L1 bioassays for cancer immunotherapy.
Liu D; Wang S; Bindeman W
J Hematol Oncol; 2017 May; 10(1):110. PubMed ID: 28514966
[TBL] [Abstract][Full Text] [Related]
20. Enhancer transcription reveals subtype-specific gene expression programs controlling breast cancer pathogenesis.
Franco HL; Nagari A; Malladi VS; Li W; Xi Y; Richardson D; Allton KL; Tanaka K; Li J; Murakami S; Keyomarsi K; Bedford MT; Shi X; Li W; Barton MC; Dent SYR; Kraus WL
Genome Res; 2018 Feb; 28(2):159-170. PubMed ID: 29273624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
